BREAKING NEWS: Stocks Start December With More Gains
Toggle navigation
About Us
Who We Are
About Bernie Schaeffer
Our Newsroom
FAQ
Contact Us
Corrections
Ethics & Fact Checks Policy
Market News
Sign Up for Free Market Newsletters
Opening View
Midday Market Check
Market Recap
View All Free Subscriptions
Schaeffer's Volatility Scorecard
Featured Publication
From the Top
Monday Morning Outlook
Indicator of the Week
Editor's Picks
View All
Trading Analysis
Best & Worst Stocks
Earnings Preview
Investor Sentiment
Quantitative Analysis
Technical Analysis
VIX & Volatility
View All
Stock Options
Intraday Options Activity
Most Active Options
Trade Postmortems
Options Recommendations
View All
Trading Education
Strategies & Concepts
Expectational Analysis
View All
Market News
Buzz Stocks
Stocks on the Move
Analyst Update
5 Minute Market Rundown
Stock Market Podcasts
View All
Daily Market Newsletters
Opening View
Midday Market Check
Market Recap
View All
Trade Alerts
All Trading Services
Most Popular Services
Elite Trader
Quick-Hit Trader
Lightning Trader
Ultimate Trader
View All
Directional Trading
Options Under $5
Leverage
Weekly Options Trader
Event Trader
PowerTrend
Schaeffer's Players
Overnight Trader
View All
Advanced Trading Alerts
Wealthbuilder
Premium Trader
Hedge Hunter
Volatility Trader
Weekly Volatility Trader
View All
Weekend Alert
Weekend Player
Weekend Trader Alert
Expiration Week Countdown
Weekly Options Countdown
View All
Newsletter Trading Services
Master Portfolio
The Option Advisor
Schaeffer's Daily Bulletin
View All
Courses & Education
Getting Started with Options
View All
Options 101
Deals
Deal of the Week
Broker Center
Free Trial
Log-In
Search
content-search-index
Tag: BMY
BMY
5
SEARCH RESULTS FOR: "Tag: BMY"
REFINE YOUR SEARCH
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2023
(5)
2022
(2)
2021
(3)
2020
(3)
2019
(11)
2018
(6)
2017
(9)
2016
(13)
2015
(10)
2014
(3)
CATEGORIES
5-Minute Market Rundown
(1)
Analyst Downgrades
(3)
Analyst Update
(5)
Analyst Upgrades
(1)
Best and Worst Stocks
(1)
Buzz Stocks
(11)
Earnings Preview
(1)
Editor's Pick
(1)
Expectational Analysis
(1)
General
(8)
Indicator of the Week
(1)
Intraday Option Activity
(6)
Midday Market Check
(7)
Opening View
(4)
Options Recommendations
(1)
Quantitative Analysis
(3)
Stock Market News
(5)
Stocks On the Move
(9)
The Week Ahead
(2)
Trade Postmortem
(1)
Trader Content
(1)
Unusual Trading Activity
(1)
Wall Street Brushed Off Inflation Data This Week
https://www.schaeffersresearch.com/content/news/2023/10/13/wall-street-brushed-off-inflation-data-this-week
10/13/2023 2:29 PM
The devastating Israel-Hamas war provided a worrisome geopolitical backdrop this week, causing oil prices to rise and U.S. Treasury yields to make large, volatile swings. Stocks, for the most part,...
Analysts Target Biotech Name on Buyout Buzz
https://www.schaeffersresearch.com/content/options/2023/10/09/analysts-target-biotech-name-on-buyout-buzz
10/9/2023 3:03 PM
Mirati Therapeutics Inc (NASDAQ:MRTX) stock is dropping today, after news that Bristol-Myers Squibb (BMY) will acquire the company for up to $5.8 billion. MRTX was down 5.2% at $57.09 at last glance,...
Pharma Stock Nears 2-Year Low on Multi-Billion Dollar Deal
https://www.schaeffersresearch.com/content/news/2023/10/09/pharma-stock-nears-2-year-low-on-multi-billion-dollar-deal
10/9/2023 2:10 PM
Shares of major pharmaceutical name Bristol-Myers Squibb Co (NYSE:BMY) are 0.2% lower at $56.54 at last glance, and touched a nearly two-year low of $55.70, after the company agreed to acquire Mirat...
Bearish Bet on Pharma Stock Doubled Investors' Money
https://www.schaeffersresearch.com/content/options/2023/09/18/bearish-bet-on-pharma-stock-doubled-investors-money
9/18/2023 2:32 PM
Subscribers to Schaeffer's Leverage Trader service more than doubled their investment with our Bristol-Myers Squibb Co (NYSE:BMY) September 63 put recommendation, all in in just two weeks. Below, w...
Multiple Reasons to Keep Off This Pharma Stock
https://www.schaeffersresearch.com/content/analysis/2023/08/30/multiple-reasons-to-keep-off-this-pharma-stock
8/30/2023 1:42 PM
Bristol-Myers Squibb Co (NYSE:BMY) is down 0.7% to trade at $62.42 at last check, after the Biden administration included the pharmaceutical name's blood thinner Eliquis in its list of 10 prescriptio...
LOAD MORE
PEOPLE ALSO SEARCH FOR
AAPL
AMGN
ARIA
BBRY
BIDU
BMY
CELG
CSX
DIS
DJI
DJIA
ESPR
exel
FB
GOOGL
GS
LLY
LNKD
MRK
MRTX
MYL
Myok
NFLX
NKTR
NYSE-BMY
PDCE
PFE
spot
SPX
TGT
TSLA
TWTR
Click here to join now and get 50% off!
Click here to join now and get 50% off!